NCT06115239View on ClinicalTrials.gov

QOL After SURGERY and ADJUVANT Treatment

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions
Carcinoma, Non-Small-Cell LungQuality of Life
Interventions
OTHER

Questionnaires

The patients will fulfill the EORTC-LC29 and HADS questionnaires in 5 different moments.

Trial Locations (1)

37007

Hospital Clínico Universitario, Salamanca

All Listed Sponsors
lead

University of Salamanca

OTHER

NCT06115239 - QOL After SURGERY and ADJUVANT Treatment | Biotech Hunter | Biotech Hunter